ReviewClinical pharmacokinetics2016

How 'Optimal' are Optimal Sampling Times for Tyrosine Kinase Inhibitors in Cancer? Practical Considerations.

Michael B Ward et al.PubMed ↗Publisher ↗

No numbers read from the abstract.